Early screening for Duchenne muscular dystrophy can help you get early treatments and referrals for your child to help prevent further loss of muscle tissue. Duchenne muscular dystrophy (DMD ...
Participants in the FORWARD-53 trial had clinically significant improvements in time-to-rise, among other metrics.
It is a fine line encouraging function, maintaining strength or some improvement, without the breakdown of muscle tissue.” No one-size-fits-all exercise works for everyone with DMD. In fact ...
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida, discusses gene therapy considerations for pediatric patients and how newborn screening can influence outcomes for ...
WVE-N531 demonstrated statistically significant improvements in muscle biopsy measures and functional measures in patients ...
As it gears up to submit an approval application next year, Wave Life Sciences has presented fresh phase 2 data showing its ...
Get Instant Summarized Text (Gist) Duchenne muscular dystrophy (DMD), primarily known for muscle degeneration, also significantly impacts the brain, leading to cognitive and behavioral issues. The ...
Wave Life Sciences Ltd. plans to file with the U.S. FDA for accelerated approval of WVE-N531, an exon skipping ...
Trial achieved key objectives for safety, tolerability, pharmacokinetics and pharmacodynamicsClinical data from this trial, together with ...
In DMD, muscle fibres are highly susceptible to injury ... impairment of muscle regeneration and muscle replacement by fibrotic and fat tissue. 4, 5-7 The disease primarily affects boys, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback